Objective: This evidence-based clinical practice guideline (CPG) aims to improve clinical decision making of general practitioners and specialists in the treatment of acute and chronic rhinosinusitis in adults. Support clinicians in clinical decision making for medical treatment with target in the pathophysiological process and evidence-based efficacy, safety, and tolerability.
Method:
The Pan-American Association of Otorhinolaryngology and Head and Neck Surgery, in partnership with the Ibero American Agency for Development and Assessment of Health Technologies, developed a clinical practice guideline on medical management of acute and chronic rhinosinusitis in adults. This document provides punctual evidence-based recommendations for primary care physicians and otolaryngologists on the medical management of these conditions and complies with evidence-based medicine fundamentals and with well-validated guidelines methodology as recommended by the National Institute for Clinical Excellence, the National Institutes of Health, and The Scottish Intercollegiate Guidelines Network.
Results: This document provides from A Grade to D Grade clinical recommendations for treatment of these conditions. The Guideline Development Group made recommendations based on well-designed, randomized controlled trials and systematic reviews. Some clinical questions could not be answered by high quality research and for these questions a Panel Delphi was conducted to provide clinical guidance. Overall there is a need for well-designed RCTs and economic assessments to answer most of the gaps of knowledge for the treatment of acute and chronic rhinosinusitis.
Conclusion: This clinical practice guideline provides guidance for the medical treatment of adults with acute and chronic rhinosinusitis.
Rhinology/Allergy Polyp Recurrence Rate in Chronic Rhinosinusitis Phenotypes
Tsuguhisa Nakayama, MD (presenter); Tetsushi Okushi; Daiya Asaka; Shin-Ichi Haruna; Hiroshi Moriyama; Nobuyoshi Otori
Objective: We proposed that chronic rhinosinusitis (CRS) is classified by 4 phenotypes in the previous study. Three phenotypes in the 4 were well classified by nasal polyps and mucosal eosinophil count. In this study we investigated the difference of recurrence rate of nasal polyps after endoscopic sinus surgery between these three phenotypes.
Method: This study was a prospective collecting data and retrospective analysis. All patients were followed up for at least 180 days after endoscopic sinus surgery. We defined mucosal eosinophilia as over 80 eosinophils under high-power magnification. Disease-free survival curves were drawn using the Kaplan-Meier method and compared using logrank test.
Results: A total of 264 of the 375 patients were enrolled in the study. The mean follow-up period was 540.4 days. Polyp recurrence was significantly different between the 3 groups (P = .016). Patients with cluster 4 (eosinophilic CRSwNP) had a higher polyp recurrence rate than cluster 2 (non-eosinophilic CRSwNP; P = .047) and cluster 1 (non-eosinophilic CRSsNP; P = .005). Cluster 1 and cluster 2 had no significant difference (P = .362).
Conclusion:
We demonstrated polyp recurrence rate was different between the three phenotypes.
Rhinology/Allergy Quality of Life in Chronic Rhinosinusitis
Aaron K. Remenschneider, MD (presenter); Ralph B. Metson, MD Objective: 1) Establish baseline characteristics of patients with chronic rhinosinusitis using a novel general quality of life instrument, the European Quality of Life 5-Dimension survey (EQ-5D). 2) Compare patients with chronic rhinosinusitis with healthy individuals and with patients with common chronic medical conditions. Method: From February 2011-2012, preoperative quality of life data were obtained from 225 patients with chronic rhinosinusitis prior to surgery at Massachusetts Eye and Ear Infirmary. Global function as well as to 5 distinct parameters (mobility, self-care, activity, pain, anxiety) were compared against published values for healthy and disease controls.
Results: General quality of life as measured using the EQ-5D visual analog scale revealed that patients with chronic
